Clinical Trials Browser

Phase 2 × Stomach Neoplasms × infigratinib × Clear all

NCT06206278 2024-08-14

Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma

Phase 2 Terminated

Gastrointestinal

Stomach Neoplasms

NCT05019794 2022-06-27

FGFR

Phase 2 Unknown

Gastrointestinal

Acrocephalosyndactylia, Stomach Neoplasms